Author(s):
Dolly Dewangan, Jitendra Yadav, Kamraj, Krity Gupta, Manish Kumar Sahu, Parimal Verma, Prashant Kumar Sahu, Shweta Sinha, Aakanksha Sinha, S. J. Daharwal
Email(s):
dollydewangan2543@gmail.com
DOI:
10.52711/0974-4150.2025.00064 
Address:
Dolly Dewangan*, Jitendra Yadav, Kamraj, Krity Gupta, Manish Kumar Sahu, Parimal Verma, Prashant Kumar Sahu, Shweta Sinha, Aakanksha Sinha, S. J. Daharwal
University Institute of Pharmacy, Pt. Ravishankar Shukla University, Raipur (C.G).
*Corresponding Author
Published In:
Volume - 18,
Issue - 6,
Year - 2025
ABSTRACT:
A simple and accurate, rapid method had been developed for determination of Quetipine fumarate in bulk and pharmaceutical dosage form. Quetipine fumarate is a 2nd generation a typical antipsychotic used for management of psychosis, Schizophrenia. The solvent, method, analytical procedure, reaction time, solvent concentration used are carefully optimised with maximum sensitivity. The proposed methods were successfully applied for the determination of QTF in pharmaceutical formulations.
Cite this article:
Dolly Dewangan, Jitendra Yadav, Kamraj, Krity Gupta, Manish Kumar Sahu, Parimal Verma, Prashant Kumar Sahu, Shweta Sinha, Aakanksha Sinha, S. J. Daharwal. A Review on Development of Analytical Methods for estimation of Quetipine fumarate in Bulk and Pharmaceutical Formulation. Asian Journal of Research in Chemistry. 2025; 18(6):427-3. doi: 10.52711/0974-4150.2025.00064
Cite(Electronic):
Dolly Dewangan, Jitendra Yadav, Kamraj, Krity Gupta, Manish Kumar Sahu, Parimal Verma, Prashant Kumar Sahu, Shweta Sinha, Aakanksha Sinha, S. J. Daharwal. A Review on Development of Analytical Methods for estimation of Quetipine fumarate in Bulk and Pharmaceutical Formulation. Asian Journal of Research in Chemistry. 2025; 18(6):427-3. doi: 10.52711/0974-4150.2025.00064 Available on: https://www.ajrconline.org/AbstractView.aspx?PID=2025-18-6-9
REFERENCE:
1. Ahsaana Hamsa, Kokilambigai Karumandampalayam Shanmugaramasamy, Praseetha Kariyarambath, Singaram Kathirvel. Quetiapine Fumarate: A Review of Analytical Methods. Journal of Chromatographic Sconce. 2023; 61(9): 892–906,
2. Rezaei, M., Ramazani, A. and Hokmabadi, F. Quetiapine fumarate syntheses and its determination methods in the pharmaceutical dosage forms, human plasma and urine by RP-HPLC and other analytical techniques: a review. Chemical Methodologies. 2018; 2(2): 141-165.
3. Reddy, B.V., Anuradha, V. and Ramachandran, D. Analytical method validation for the determination of fumaric acid content in quetiapine hemi fumarate by RP-HPLC. American Journal of Pharm Tech Research. 2020; 10(2): 122-133.
4. Venkata, K.B., Battula, S.R. and Dubey, S. Validation of quetiapine fumarate in pharmaceutical dosage by reverse‐phase HPLC with internal standard method. Journal of Chemistry. 2013; 2013(1): 578537.
5. Krishna, S.R., Rao, B.M. and Rao, N.S. A validated stability indicating HPLC method for the determination of related substances in quetiapine fumarate. Rasayan Journal of Chemistry. 2008; 1(3): 466-474.
6. Nagaraju, P. Development and Validation of RP-HPLC Method for Estimation of Quetiapine Fumarate in Pharmaceutical Formulations. Pharmaceutical Methods. 2015; 6(2).
7. Nemeroff, C.B., Kinkead, B. and Goldstein, J. Quetiapine: preclinical studies, pharmacokinetics, drug interactions, and dosing. Journal of Clinical Psychiatry. 2002; 63(13): 5-11.
8. Goldstein, J.M., 1999. Quetiapine fumarate (Seroquel): a new atypical antipsychotic. Drugs of Today (Barcelona). 1998; 35(3): 193-210.
9. Ritika Shrivastava, Aakanksha Sinha and Jitendra Yadav. Review on various analytical and bio analytical methodologies for fluconazole. International Journal of Development Research. 2025; 15(4): 68172-68175 DOI: https://doi.org/10.37118/ijdr.29468.03.2025
10. Verma, G. and Mishra, M., 2018. Development and optimization of UV-Vis spectroscopy-a review. World J. Pharm. Res, 7(11), pp.1170-1180.
11. SB, B., Narkhede, S., Nikam, D. and Sachde, C.K., 2009. Development and validation of UV-Spectrophotometric method for determination of Quetiapine fumarate in two different dose tablets. Int J Chem Tech Res, 1, pp.898-904.
12. Eapen, S.C., Prasanth, V.G., Kutty, S.V., Jyothi, T.S. Development and validation of UV-spectrophotometric method for determination of quetiapine fumarate in pure and pharmaceutical formulation. International Journal of Pharmacy and Technology. 2011; 3(4): 3535–3542.
13. Chhajed, S.S., Agrawal, S.S., Bastikar, V.A., Gosavi, R.A., Kunte, S.H., Wagh, R.D. Estimation of quetiapine in bulk drug and tablet dosage form. International Journal of Chemical Sciences. 2009; 7(2): 951–960.
14. Basavaiah, K., Rajendra prasad, N., Ramesh, P.J., Vinay, K.B. Sensitive ultraviolet spectrophotometric determination of quetiapine fumarate in pharmaceuticals. Thai Journal of Pharmaceutical Sciences. 2010; 34(4): 146–154.
15. Hiraman, B.B., Vidhate, S. Spectrophotometric determination of an atypical antipsychotic compound in pharmaceutical formulation. International Journal of Chem Tech Research. 2009; 1(4): 1153–1161.
16. Ramadan, N.K., Mohamed, A.O., Fouad, R.M., Moustafa, A.A. Different stability-indicating methods for the determination of quetiapine fumarate. Analytical Chemistry. 2013; 12(7): 264–276.
17. Srihari, G., Chakravarthi, I.E. Simple spectrophotometric method for determination of quetiapine fumarate in tablets. International Journal of Chemical Sciences. 2011; 9(2): 949–952.
18. Vinay, K.B., Revanasiddappa, O., Ramesh, J., Rajendra Prasad, N. Titrimetric and sensitive spectrophotometric methods for the assay of quetiapine fumarate in pharmaceutical formulations. Chemical Industry and Chemical Engineering Quarterly. 2011; 17(1): 99–106.
19. Pucci, V., Mandrioli, R., Ferranti, A., Furlanetto, S., Raggi, M.A. Quality control of commercial tablets containing the novel antipsychotic quetiapine. Journal of Pharmaceutical and Biomedical Analysis. 2003; 32(4–5): 1037–1044. https://doi.org/10.1016/S0731-7085(03)00206-1.
20. Rajendra prasad, N., Basavaiah, K., Vinay, K.B. Sensitive and selective extraction-free spectrophotometric determination of quetiapine fumarate in pharmaceuticals using two sulphonthalein dyes. Journal of Pre-Clinical and Clinical Research. 2010; 4(1): 24.
21. Arulappa, R.X., Sundarapandian, M., Venkataraman, S., Boopathi, M., Kauraw, M. Spectrophotometric determination of quetiapine fumarate in bulk and dosage form. Research Journal of Pharmacy and Technology. 2009; 2(4): 884–885.
22. Rajendra prasad, N., Basavaiah, K., Vinay, B.K. Extractive spectrophotometric determination of quetiapine fumarate in pharmaceuticals and human urine using calmagite as an ion-pair reagent; Chemical Industry and Chemical Engineering Quarterly, (2011); 17(3): 25967. https://doi.org/10.2298/CICEQ101124010R.
23. Suresh, C.V., Rao, S.K.R.S., Vidyasagar, G. Development of new visible spectrophotometric methods for the determination of quetiapine in pharmaceutical dosage forms. Bulletin of Pharmaceutical Research. 2011; 1(3): 31–33.
24. Singh, R. HPLC method development and validation-an overview. Journal of Pharmaceutical Education and Research. 2013; 4(1).
25. Klausz, G., Keller, É., Sára, Z., Székely‐Körmöczy, P., Laczay, P., Ary, K., Sótonyi, P. and Róna, K., 2015. Simultaneous determination of praziquantel, pyrantel embonate, febantel and its active metabolites, oxfendazole and fenbendazole, in dog plasma by liquid chromatography/mass spectrometry. Biomedical Chromatography, 29(12), pp.1859-1865.
26. Talele, S.G. Stability-indicating high-performance liquid chromatography (HPLC) method development and validation for the determination of quetiapine fumarate in bulk and dosage form by HPLC. International Journal of Green Pharmacy. 2018; 12(1): S188–S193. https://doi.org/10.22377/ijgp.v12i01.1618.
27. Ramadan, N.K., Mohamed, A.O., Fouad, R.M., Moustafa, A.A. Different stability-indicating methods for the determination of quetiapine fumarate. Analytical Chemistry. 2013; 12(7): 264–276.
28. Davis, P.C., Wong, J., Gefvert, O. Analysis and pharmacokinetics of quetiapine and two metabolites in human plasma using reversed-phase HPLC with ultraviolet and electrochemical detection. Journal of Pharmaceutical and Biomedical Analysis. 1999; 20(1–2): 271–282. https://doi.org/10.1016/S0731-7085(99)00036-9.
29. Tran, J., Gervase, M.A., Evans, J., Deville, R., Dong, X. The stability of quetiapine oral suspension compounded from commercially available tablets. PLoS One. 2021; 16(8): e0255963. https://doi.org/10.1371/journal.pone.0255963.
30. Nuchtavorn, N., Leanpolchareanchai, J., Chanton, D. A rapid stability indicating HPLC method for determination of quetiapine fumarate in tablets and extemporaneous formulations. Pharmaceutical Chemistry Journal. 2021; 55(8): 845–854. https://doi.org/10.1007/s11094-021-02505-x.
31. Sawsan, M., Hesham, S., Marianne, N., El-Maraghy, M. Vali. HPLC and thin layer-densitometric methods for determination of quetiapine fumarate in presence of its related compounds. Journal of Chromatography and Separation Techniques. 2015; 6(5): 279–285.
32. Dedania, Z.R., Dedania, R.R., Sheth, N.R. Stability indicating HPLC determination of quetiapine fumarate. World Journal of Pharmaceutical Research. 2015; 4(6): 1474–1486.
33. Swain, S., Sahu, P.K. Stress testing of quetiapine fumarate by a chemometric assisted multi-component ion-interaction system. Pharmaceutical Regulatory Affairs. 2017; 6(188): 1–7.
34. Krishna, S.R., Rao, B.M., Rao, N.S. A validated stability indicating HPLC method for the determination of related substances in quetiapine fumarate. Rasayan Journal of Chemistry. 2008; 1(3): 466–474.
35. Somaraju, I.V., Raghuram, P., Sriramulu, J. Development and validation of a new analytical method for the determination of related components in quetiapine hemifumarate. Chro matographia. 2009; 70(3): 545–550.
36. Kumar, A., Jawla, S. and Yadav, G. Recent analytical method developed by RP-HPLC. Global Journal of Pharmacology. 2013; 7(3): 232-240.
37. Gupta, S., Verma, P., Mishra, A.P., Omar, N. and Mathur, R. A review on novel analytical method development and validation by RP-HPLC method. Indian Journal of Forensic Medicine and Toxicology. 2021; 15(4): 3479-3486.
38. Kirthi, A., Shanmugam, R., Prathyusha, M.S. and Basha, D.J.,. A review on bioanalytical method development and validation by RP-HPLC. Journal of Global Trends in Pharmaceutical Sciences. 2014; 5(4): 2265-2271.
39. Rosa, P.C., Pires, I.F., Markman, B.E., Perazzo, F.F. Development and validation of RP-HPLC method for the determination of related compounds in quetiapine hemifumarate raw material and tablet. Journal of Applied Pharmaceutical Science. 2013; 3(8): 6. https://doi.org/10.7324/JAPS.2013.3802.
40. Pant, M., Khatri, N.C. Development and validation of assay method for estimation of quetiapine fumarate by RP-HPLC. International Journal of Pharmacy and Life Sciences. 2012; 3(7): 1802.
41. Reddy, S.P., Satyanarayana, P., Verma, K.K., Naga, R., Kumar, S., Sundaram, S.P. Novel reverse phase HPLC method development and validation of quetiapine fumatrate in bulk and tablet dosage form. International Journal of Pharmaceutical Research. 2011; 1(2): 95–99.
42. Korrapolu, S., Bollineni, S., Nalluri, B.N. Stability indicating RPHPLC-PDA method for the estimation of quetiapine fumarate in bulk and pharmaceutical dosage forms. Journal of Chemical and Pharmaceutical Research. 2012; 4(8): 3877–3884.
43. Suneetha, D., Rao, L.A. A validated RP-HPLC method for the estimation of quetiapine in bulk and pharmaceutical formulations. E-Journal of Chemistry. 2010; 7(S1): S261–S266. https://doi.org/10.1155/2010/105963.
44. Reddy, B.V., Anuradha, V., Ramachandran, D. Analytical method validation for the determination of fumaric acid content in quetiapine hemi fumarate by RP-HPLC. American Journal of Pharm Tech Research. 2020; 10(2): 122–133.
45. Benjamin, T., Ramachandran, D. Development and validation of stability indicating RP-HPLC method for quantitative estimation of quetiapine fumarate and its impurities in drug substance as per ICH guidelines. European Journal of Biomedical and Pharmaceutical Sciences. 2019; 6(2): 243–250.
46. Chandra, R., Sanghi, A., Kumar, D., Bharti, A.K. Development and validation a RP-HPLC method: application for the quantitative determination of quetiapine fumarate from marketed bulk tablets. Journal of Chemical and Pharmaceutical Research. 2016; 8(1): 142–146.
47. Gunjal Sanket, B. and Dighe, P.R. Analysis of herbal drugs by HPTLC: A review. Asian Journal of Pharmaceutical Research and Development. 2022; 10(2):.125-128.
48. Sikdar, K. M. Yasif Kayes, Hayley Andrews, Kate Pacecca, Aliyah Petker, Sarah Samie, Tomislav Sostaric, Lee Yong Lim, Md Khairul Islam, and Cornelia Locher. Development and Validation of a Stability-Indicating HPTLC-Based Assay for the Quantification of Nitrofurazone Ointment. Molecules. 2025; 30(16): 3429. https://doi.org/10.3390/molecules30163429
49. Miniyar, P.B., Thomas, A.B., Kulkarni, R.D., Kadam, S.A., Chouhan, P.P., Chitlange, S.S. Development of an analytical method for identification of the genotoxic impurity of quetiapine fumarate by high-performance thin-layer chromatography. Journal of Planar Chromatography–Modern TLC. 2019; 32(4): 317–321. https://doi.org/10.1556/1006.2019.32.4.6.
50. Sathiya, R., Krishnaraj, K., Muralidharan, S., Muruganantham, N. A simple and validated HPTLC method of evaluation for quetiapine fumarate in oral solid dosage form. Eurasian Journal of Analytical Chemistry. 2010; 5(3): 246–253.
51. Dhandapani, B., Somasundaram, A., Raseed, S.H., Raja, M., Dhanabal, K. Development and validation of HPTLC method for estimation of quetiapine in bulk drug and in tablet dosage form. International Journal of Pharm Tech Research. 2009; 1(2): 139–141.
52. Miniyar, P.B., Kulkarni, R.D., Thomas, A.B., Chitlange, S.S. Development and validation of an analytical method for the identification of 2-nitrophenyl (phenyl) sulfane as potential genotoxic impurity of quetiapine fumarate at trace levels by high-performance thin-layer chromatography. JPC Journal of Planar Chromatography Modern TLC. 2019; 32(6): 511–516. https://doi.org/10.1556/1006.2019.32.6.10.
53. Sawsan, M., Hesham, S., Marianne, N., El-Maraghy, M. Validated HPLC and thin layer-densitometric methods for determination of quetiapine fumarate in presence of its related compounds. Journal of Chromatography and Separation Techniques. 2015; 6(5): 279–285.
54. Dedania, Z.R., Sheth, N.R., Dedania, R.R. Stability indicating high-performance thin-layer chromatographic determination of quetiapine fumarate. International Journal of Pharmaceutical Sciences and Research. 2013; 4(6): 2406. https://doi.org/10.13040/IJPSR.0975-8232.4(6).2406-14.
55. Dhaneshwar, S.R., Patre, N.G., Mahadik, M.V. Stability indicating HPTLC method for quantitation of quetiapine fumarate in the pharmaceutical dosage form. Acta Chromatographica. 2009; 21(1): 83–93. https://doi.org/10.1556/ achrom.21.2009.1.7.
56. Bevz, O., Sych, I., Shaposhnyk, A., Kryvanych, O., Taran, S., Perekhoda, L. Development of determination methods of quetiapine fumarate for forensic-pharmaceutical purposes. Science Rise: Pharmaceutical Science. 2021; 2(30): 4–12. https://doi.org/10.15587/2519-4852.2021.228132.
57. Ramadan, N.K., Mohamed, A.O., Fouad, R.M., Moustafa, A.A. Different stability-indicating methods for the determination of quetiapine fumarate. Analytical Chemistry. 2013; 12(7): 264–276.
58. Xu, H., Wang, D., Sun, C., Pan, Y., Zhou, M. Identification of an unknown trace-level impurity in bulk drug of Seroquel by high performance liquid chromatography combined with mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 2007; 44(2): 414–420.
59. Diego, M., Campos, C., Correa, D., Mennickent, S., Godoy, R., Vergara, C. Degradation studies of quetiapine fumarate by liquid chromatography–diode array detection and tandem mass spectrometry methods. Biomedical Chromatography. 2019; 33(11): e4655. https://doi.org/10.1002/bmc.4655.
60. Moein, M.M., El Beqqali, A. and Abdel-Rehim, M. Bioanalytical method development and validation: Critical concepts and strategies. Journal of Chromatography B. 2017; 1043:.3-11.
61. Abdul rahman MM, Kalyani Rupnawar, Madhuri A. Nagras and Supriya A. Unavane. A review on Bioanalytical Method Development, Validation and Techniques used for Pharmacokinetic studies using LCMS/MS, Contemporary Investigations and Observations in Pharmacy, 2012; 1(2): 63-71.
62. Puluido A, Ruusanches I, Boque R and Rius FX. Uncertainty of results in routine Qualitative Analysis in Analytical Chemistry. J Pharm Biomed Anal. 2005; 22: 647–54.
63. Rajendra prasad, N., Basavaiah, K., Vinay, K.B. Extractive spec trophotometric determination of quetiapine fumarate in phar maceuticals and spiked human urine. Croatica Chemica Acta. 2012; 85(1): 9–17.
64. Belal, F., Elbrashy, A., Eid, M., Nasr, J.J. Stability-indicating HPLC method for the determination of quetiapine: application to tablets and human plasma. Journal of Liquid Chromatography and Related Technologies. 2008; 31(9): 1283–1298. https://doi.org/10.1080/10826070802019681.
65. Hopenwasser, J., Mozayani, A., Danielson, T.J., Harbin, J., Narula, H.S., Posey, D.H., et al. Postmortem distribution of the novel antipsychotic drug quetiapine. Journal of Analytical Toxicology. 2004; 28(4): 264–268.
66. Zhao-Ao, C.H., Zhu-Jun, L. Determination of the concentration of quetiapine in human plasma by HPLC with UV detection. Strait Pharmaceutical Journal. 2010; 2: 168–170.
67. Youssef, R.M., Abdine, H.H., Barary, M.A., Wagih, M.M.; Selective RP-HPLC method for determination of quetiapine in presence of administered drugs: application for long-term stability study of quetiapine in whole blood. Acta Chromatographica. 2016; 28(3): 263–279. https://doi.org/10.1556/1326.2016.28.2.2.
68. Dalvi, S.D., Nanda, R.K., Soham, S.C. Design of experiment in the bio-analytical determination of quetiapine fumarate in human plasma by an RP-HPLC method. International Journal of Pharmaceutical Sciences and Research. 2018; 9(7): 2875–2882. https://doi.org/10.13040/IJPSR.0975-8232.9(7).2875-82.
69. Peddio, G., Pittau, B., Manca, I., Salis, R., Pani, L., Pira, L. Validated method to determine quetiapine and norquetiapine in microsomal matrix by LC/MS–MS: implication in quetiapine metabolism. Chromatographia. 2014; 77(1–2): 75–82.
70. Xiong, X., Yang, L., Duan, J. Development and validation of a sensitive and robust LC–MS/MS with electrospray ionization method for simultaneous quantitation of quetiapine and its active metabolite norquetiapine in human plasma. Clinica Chimica Acta. 2013; 423: 69–74. https://doi.org/10.1016/j.cca.2013.04.016.
71. Pan, R.N., Kuo, B.P., Pao, L.H. Validated LC–MS-MS method for the determination of quetiapine in human plasma: application to a pharmacokinetic study. Journal of Chromatographic Science. 2012; 50(3): 277–282. https://doi.org/10.1093/chromsci/bms001.
72. Barrett, B., Holcapek, M., Huclova, J., Borek-Dohalsky, V., Fejt, P., Nemec, B., et al. Validated HPLC–MS/MS method for deter mination of quetiapine in human plasma. Journal of Phar maceutical and Biomedical Analysis. 2007; 44(2): 498–505. https://doi.org/10.1016/j.jpba.2007.03.034.
73. Mostafa, I.M., Omar, M.A., Nagy, D.M., Derayea, S.M. Analysis of quetiapine in human plasma using fluorescence spectroscopy; Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2018; 196: 196–201 https://doi.org/10.1016/j.saa.2018.02.019.
74. Atanasov, V.N., Kanev, K.P., Mitewa, M.I. Detection and identification of a typical quetiapine metabolite in urine. Central European Journal of Medicine. 2008; 3(3): 327–331.
75. Wei, F., Lin, Y., Wu, Y., Sun, X., Liu, L., Zhou, P., et al. Double shell CdTe/CdS/ZnS quantum dots as a fluorescence probe for quetiapine determination in fumarate quetiapine tablets. Analyt ical Methods. 2014; 6(2): 482–489.